278
Views
16
CrossRef citations to date
0
Altmetric
Original

Anhedonia and Social Adaptation Predict Substance Abuse Evolution in Dual Diagnosis Schizophrenia

, Ph.D., , M.D., M.Sc., , M.D., , M.D., , M.Sc., , M.D. & , Ph.D. show all
Pages 75-82 | Published online: 24 Aug 2009

REFERENCES

  • Kavannagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia. Drugs 2002; 62:743–755.
  • Regier DA, Farmer ME, Raes DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990; 264:2511–2518.
  • Khantzian EJ. The self-medication hypothesis of substance use disorders: A reconsideration and recent applications. Har Rev Psychiatry 1997; 4:231–244.
  • Khantzian EJ. The self-medication hypothesis of substance use disorders: Focus on heroin and cocaine dependence. Am J Psychiatry 1985; 142:1259–1264.
  • Mueser KT, Yarnold PR, Rosenberg SD, Swett C, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups. Schizophr Bull 2000; 26:179–192.
  • Potvin S, Sepehry AA, Stip E. A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychol Med 2006; 36:431–440.
  • Talamo A, Centorrino F, Tondo L, Dimitri A, Hennen J, Baldessarini RJ. Comorbid substance-use in schizophrenia: Relation to positive and negative symptoms. Schizophr Res 2006; 86(1–3):251–255.
  • Tien AY, Anthony JC. Epidemiological analysis of alcohol and drug use as risk factors for psychotic experiences. J Nerv Ment Dis 1990; 178:473–480.
  • Mueser KT, Drake RE, Wallach MA. Dual diagnosis: A review of etiological theories. Addict Behav 1998; 23:717–734.
  • Veen ND, Selten JP, van der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age at onset of schizophrenia. Am J Psychiatry 2004; 161:501–506.
  • Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. Brit Med J 2002; 325:1212–1213.
  • Henquet C, Murray R, Linszen D, van Os J. The environment and schizophrenia: The role of cannabis use. Schizophr Bull 2005; 31:608–612.
  • Bersani G, Orlandi V, Kotzalidis GD, Pancheri P. Cannabis and schizophrenia: Impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatr Clin Neurosci 2002; 252:86–92.
  • Serper MR, Chou JCY, Allen MH, Czobor P, Cancro R. Symptomatic overlap of cocaine intoxication and acute schizophrenia at emergency presentation. Schizophr Bull 1999; 25:387–394.
  • Potvin S, Stip E, Lipp O, Élie R, Mancini-Marië A, Demers MF, Roy MA, Bouchard RH, Gendron A. Quetiapine in patients with schizophrenia-spectrum and substance use disorders: An open-label trial. Curr Med Res Op 2006; 22:1277–1285.
  • Srisurapanont M, Maneeton B, Maneeton N. Quetiapine for schizophrenia. Cochrane Database Syst Rev 2004; 2:CD000967.
  • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13:261–276.
  • Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In Measuring Alcohol Consumptions: Psychosocial and Biochemical Methods. Littren RZ, Allen JP, eds. Towota: Humana Press, 1992; 41–72.
  • Drake RE, Osher FC, Noordsy DL, Hurlburt SC, Teague GB, Beaudett MS. Diagnosis of alcohol use disorders in schizophrenia. Schizophr Bull 1990; 16(1):57–67.
  • Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res 1990; 3:247–251.
  • Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol 1976; 4:374–382.
  • Weissman MM, Sholomskas D, John K. The assessment of social adjustment: An update. Arch Gen Psychiatry 1981; 38:1250–1258.
  • Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: An impact on community survival 4 years after relapse. Schizophr Res 2002; 54:253–264.
  • Margolese HC, Negrete JC, Tempier R, Gill K. A 12-month prospective follow-up study of patients with schizophrenia-spectrum disorders and substance abuse: Changes in psychiatric symptoms and substance use. Schizophr Res 2006; 83(1):65–75.
  • Negrete JC. Clinical aspects of substance abuse in persons with schizophrenia. Canad J Psychiatry 2003; 55:109–113.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.